ArticleMedicina (Kaunas, Lithuania)2026
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer.
Ali Aytac, Bilgin Demir, Meltem Demirtas Gulmez, Hayati Arvas, Tuba Ugur Tuzcu, Enes Erul, Salih Tunbekici, Tahir Yerlikaya, Sezai Tunc, Halil Ibrahim Ellez and 10 more
Abstract readMulticenter Study
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
20 authors.
Ali AytacMedical Oncology Clinic, Mehmet Akif Inan Training and Research Hospital, University of Health Sciences, Sanliurfa 63320, Turkey.ORCID 0000-0001-9753-8517 Bilgin DemirDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Aydın Adnan Menderes University, Aydın 09100, Turkey.ORCID 0000-0003-4380-9419 Meltem Demirtas GulmezDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Aydın Adnan Menderes University, Aydın 09100, Turkey.
Hayati ArvasDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Dicle University, Diyarbakır 21000, Turkey.ORCID 0000-0003-2215-5567 Tuba Ugur TuzcuDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara 06000, Turkey.
Enes ErulDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara 06000, Turkey.ORCID 0000-0002-2487-2087 Salih TunbekiciDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Ege University, İzmir 35000, Turkey.
Sezai TuncDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Harran University, Şanlıurfa 63320, Turkey.ORCID 0000-0002-4972-9367 Halil Ibrahim EllezMedical Oncology Clinic, Mehmet Akif Inan Training and Research Hospital, University of Health Sciences, Sanliurfa 63320, Turkey.ORCID 0000-0002-9593-0942 Yasemin Aydinalp CamadanMedical Oncology Clinic, Mehmet Akif Inan Training and Research Hospital, University of Health Sciences, Sanliurfa 63320, Turkey.ORCID 0000-0003-2435-368X Kubra CanaslanMedical Oncology Clinic, Mehmet Akif Inan Training and Research Hospital, University of Health Sciences, Sanliurfa 63320, Turkey.ORCID 0000-0001-7705-3926 Rumeysa ColakMedical Oncology Clinic, Mehmet Akif Inan Training and Research Hospital, University of Health Sciences, Sanliurfa 63320, Turkey.ORCID 0000-0002-3867-0793 Zuhat UrakciDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Dicle University, Diyarbakır 21000, Turkey.
Elif Berna KoksoyDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara 06000, Turkey.ORCID 0000-0002-6590-4444 Ozan YaziciDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara 06000, Turkey.
Ali AlkanDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla 48000, Turkey.ORCID 0000-0002-8253-5046 Ozgur TanriverdiDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Muğla Sıtkı Koçman University, Muğla 48000, Turkey.ORCID 0000-0002-0598-7284 Erdem GokerDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Ege University, İzmir 35000, Turkey.ORCID 0000-0001-6180-713X Ahmet DemirkazikDivision of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara 06000, Turkey.ORCID 0000-0002-2917-7999 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoembryonic AntigenCarcinoma, Non-Small-Cell LungLung NeoplasmsAgedBiomarkers, TumorErbB ReceptorsFemaleHumansMaleMiddle AgedNeoplasm MetastasisPrognosisProportional Hazards ModelsProto-Oncogene Proteins p21(ras)Retrospective StudiesBiomarkers, TumorCarcinoembryonic AntigenErbB ReceptorsKRAS protein, humanProto-Oncogene Proteins p21(ras)carcinoembryonic antigen (CEA)metastatic non-small cell lung cancermolecular subtypesoncogenic driver mutationsoverall survivalprognosis
Identifiers
PMID42075590
PMCPMC13117239
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390